Molecular Resilience, Inc and other shareholders entered into a letter of intent to sell Fortitude Group, Inc. (OTCPK:FRTD) for $3 million in stock on May 18, 2014. The buyer will exchange each share of Fortitude with its share at consideration of $0.12 per share. The letter of intent includes a 10 day due diligence period with an estimated closing date for the transaction of May 30, 2014.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | 0.00% | 0.00% |
2021 | Analysis: Chasing yield, U.S. private equity firms nudge up risk on insurers | RE |
2021 | Chasing yield, U.S. private equity firms nudge up risk on insurers | RE |
1st Jan change | Capi. | |
---|---|---|
0.00% | 737 | |
-0.30% | 120B | |
+5.52% | 97.17B | |
+13.68% | 69.14B | |
+23.75% | 64.14B | |
+13.61% | 43.95B | |
+14.74% | 43.3B | |
+22.18% | 36.38B | |
+7.90% | 25.91B | |
+0.32% | 23.39B |
- Stock Market
- Equities
- FRTD Stock
- News Fortitude Group, Inc.
- Molecular Resilience, Inc and other shareholders entered into a letter of intent to sell Fortitude Group, Inc. for $3 million.